Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Asset Writedowns and Impairment (2022 - 2026)

Core Scientific has reported Asset Writedowns and Impairment over the past 4 years, most recently at $266.5 million for Q1 2026.

  • Quarterly results put Asset Writedowns and Impairment at $266.5 million for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $277.8 million (changed N/A YoY), and the annual figure for FY2025 was $11.4 million, changed.
  • Asset Writedowns and Impairment reached $266.5 million in Q1 2026 per CORZ's latest filing, up from $11.4 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $790.8 million in Q2 2022 and bottomed at -$784.8 million in Q3 2022.
  • Median Asset Writedowns and Impairment over the past 4 years was $11.4 million (2025), compared with a mean of $41.0 million.
  • Peak annual rise in Asset Writedowns and Impairment hit 111.68% in 2025, while the deepest fall reached 111.68% in 2025.
  • Over 4 years, Asset Writedowns and Impairment stood at $3.1 million in 2022, then crashed by 3277.43% to -$97.3 million in 2024, then skyrocketed by 111.68% to $11.4 million in 2025, then soared by 2246.05% to $266.5 million in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for CORZ at $266.5 million in Q1 2026, $11.4 million in Q4 2025, and -$97.3 million in Q4 2024.